EA200000131A1 - Иммуномодулирующая композиция на основе липидов - Google Patents

Иммуномодулирующая композиция на основе липидов

Info

Publication number
EA200000131A1
EA200000131A1 EA200000131A EA200000131A EA200000131A1 EA 200000131 A1 EA200000131 A1 EA 200000131A1 EA 200000131 A EA200000131 A EA 200000131A EA 200000131 A EA200000131 A EA 200000131A EA 200000131 A1 EA200000131 A1 EA 200000131A1
Authority
EA
Eurasian Patent Office
Prior art keywords
lipids
composition based
immunomodulating composition
immunomodulating
enriched
Prior art date
Application number
EA200000131A
Other languages
English (en)
Other versions
EA002364B1 (ru
Inventor
Мейр Шиницкий
Авнер Шенфельд
Original Assignee
Модус Байолоджикал Мембрейнс Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Модус Байолоджикал Мембрейнс Лтд. filed Critical Модус Байолоджикал Мембрейнс Лтд.
Publication of EA200000131A1 publication Critical patent/EA200000131A1/ru
Publication of EA002364B1 publication Critical patent/EA002364B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Addiction (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Фармацевтическая композиция для активации иммунной системы включает в себя липидный препарат, получаемый из натурального источника, обогащенного, по меньшей мере, на 10% фосфатидной кислотой.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200000131A 1997-07-16 1998-05-14 Применение иммуномодулирующей композиции на основе липидов EA002364B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL12132297A IL121322A (en) 1997-07-16 1997-07-16 Modular pharmacological preparation of the immune system based on fats and its preparation
PCT/IL1998/000218 WO1999003479A1 (en) 1997-07-16 1998-05-14 Lipid-based immune modulator composition

Publications (2)

Publication Number Publication Date
EA200000131A1 true EA200000131A1 (ru) 2000-06-26
EA002364B1 EA002364B1 (ru) 2002-04-25

Family

ID=11070395

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000131A EA002364B1 (ru) 1997-07-16 1998-05-14 Применение иммуномодулирующей композиции на основе липидов

Country Status (12)

Country Link
US (1) US6288047B1 (ru)
EP (1) EP0999846B1 (ru)
JP (1) JP2001510161A (ru)
CN (1) CN1181826C (ru)
AT (1) ATE258056T1 (ru)
AU (1) AU732706B2 (ru)
BR (1) BR9810884A (ru)
CA (1) CA2295690A1 (ru)
DE (1) DE69821240T2 (ru)
EA (1) EA002364B1 (ru)
IL (1) IL121322A (ru)
WO (1) WO1999003479A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6595900A (en) * 1999-08-18 2001-03-13 Kyowa Hakko Kogyo Co. Ltd. Hair growth stimulants
AU2001264079A1 (en) * 2000-06-14 2001-12-24 William Leslie Porter Lipids for modulating immune response
GB0014437D0 (en) * 2000-06-14 2000-08-09 Porter William L Immune response stimulation
EP1791548A1 (en) * 2004-07-27 2007-06-06 Modus Biological Membranes Ltd. Compositions and methods for smoking cessation
JP2009506108A (ja) * 2005-08-31 2009-02-12 モダス・バイオロジカル・メンブランズ・リミテッド 好酸球増加症および関連障害の治療用組成物
US10869843B2 (en) 2010-11-23 2020-12-22 Chemi Nutra Method for increasing muscle mass and strength

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54117034A (en) * 1978-02-28 1979-09-11 Nippon Shoji Kk Treating agent for consciousness and perception motion disorder
GB2045612B (en) * 1979-03-27 1983-04-20 Nippon Shoji Kaisha Ltd Pharmaceutical compositions containing phosphatidic acids for the treatment of disorders of consciousness perception and movement
EP0399544B1 (en) * 1989-05-26 1994-08-24 Kao Corporation Process for the production of phosphatidic acid
FR2658418B1 (fr) * 1990-02-20 1994-09-02 Synthelabo Compositions pharmaceutiques a base de phospholipides.
GB9205670D0 (en) * 1992-03-16 1992-04-29 Indena Spa New derivatives of physostigmine,their use and pharmaceutical formulations containing them
GB9212450D0 (en) * 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
WO1995013808A1 (en) * 1993-11-15 1995-05-26 Cell Therapeutics, Inc. Method for selectively inhibiting il-2 signal transduction
WO1995020967A1 (en) * 1994-02-04 1995-08-10 Cell Therapeutics, Inc. Composition for wound healing, neuron growth and vascularization
IL118180A (en) * 1996-05-08 2000-12-06 Modus Biolog Membranes Ltd Pharmaceutical compositions comprising a phosphatidic acid (PA) enriched natural phospholipid preparation and the production of such preparation

Also Published As

Publication number Publication date
EP0999846B1 (en) 2004-01-21
ATE258056T1 (de) 2004-02-15
DE69821240T2 (de) 2005-01-20
IL121322A (en) 2002-07-25
EP0999846A1 (en) 2000-05-17
DE69821240D1 (de) 2004-02-26
WO1999003479A1 (en) 1999-01-28
US6288047B1 (en) 2001-09-11
EA002364B1 (ru) 2002-04-25
JP2001510161A (ja) 2001-07-31
CN1264304A (zh) 2000-08-23
CA2295690A1 (en) 1999-01-28
AU7231598A (en) 1999-02-10
AU732706B2 (en) 2001-04-26
IL121322A0 (en) 1998-01-04
BR9810884A (pt) 2000-09-26
CN1181826C (zh) 2004-12-29

Similar Documents

Publication Publication Date Title
GEP20001898B (en) Method and Pharmaceutical Composition for Regulating Lipid Concentration with Mam
AU7044894A (en) (phospho)lipids for combatting hepatitis b virus infection
NO980354L (no) Liposomale oligonukleotidsammensetninger
MY110734A (en) Improvements in or relating to dioic acids.
FR2616328B1 (fr) Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de murier, ou au moins une flavone, en particulier une kuwanone et composition pharmaceutique, notamment dermatologique, a activite depigmentante, ou anti-inflammatoire, ou cosmetique, l'incorporant
ES2164916T3 (es) Tratamiento de la esclerosis multiple.
AU628662B2 (en) Dietary supplement and method of minimizing effects of infection through diet
ES2055911T3 (es) Compuesto farmaceutico adelgazante.
ES2061772T3 (es) Inhalante aerosol que comprende un ester de retinol y/o de acido retinico.
DK0731699T3 (da) Fremgangsmåde til reduktion af legemsfedt i dyr ved indgivelse af konjugeret linolsyre
AU1943388A (en) 3-indolepyruvic acid derivatives and pharmaceutical use thereof
FI970298A (fi) DHA:n käyttö farmaseuttisena koostumuksena
ATE245427T1 (de) Neue verwendung von phospholipiden tierischen ursprungs in der therapie und/oder schonkost
DE69201725T2 (de) Behandlungsmethoden für osteoporose.
AU3139097A (en) Methods of preventing skeletal problems in poultry
ATE223204T1 (de) Liposomenzusammensetzung
EP0722338A4 (en) PROTEIN OR PEPTIDE COCHLEATE VACCINES AND IMMUNIZATION METHODS USING THE SAME
UA35611C2 (ru) Композиция местного применения для ингибирования роста волос у млекопитающих, способ ее применения и композиция местного применения для доставки водорастворимого фармакологического средства к коже
SG81882A1 (en) Retinoid composition
EA200000131A1 (ru) Иммуномодулирующая композиция на основе липидов
EP0420979A4 (en) AGENT FOR IMPROVING LIPID METABOLISM AND METHOD OF USE.
ATE210989T1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
EP0389570A4 (en) High integrity liposomes and method of preration and use
ES8406504A1 (es) Procedimiento de preparacion de dinucleosidos-monofosfatos
ATE105479T1 (de) Verfahren zur steigerung des phosphatidylcholins in vivo.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU